Macquarie Sticks to Its Hold Rating for BHP Group Ltd (BHPLF)
BHP Price Target Cut 2% to A$42.00/Share by Macquarie
Australian Stocks: BHP Considers Selling Gold, Copper Mines in Brazil
Morgans Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
ResMed Price Target Raised to $251.00/Share From $238.00 by Keybanc
ResMed Price Target Maintained With a $236.00/Share by Needham
UBS Remains a Sell on Commonwealth Bank of Australia (CBA)
Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD) Receives a Hold From Citi
BHP Group Ltd (BHPLF) Gets a Hold From Morgan Stanley
UBS Reaffirms Their Hold Rating on BHP Group Ltd (BHPLF)
Citi Sticks to Its Buy Rating for BHP Group Ltd (BHPLF)
Macquarie Price Target Raised 1.2% to A$192.10/Share by Morgans
Evans & Partners Upgrades Ampol to Positive From Neutral; Price Target Is AU$37
ResMed Price Target Raised 1.6% to A$35.40/Share by Macquarie
Macquarie CEO Says 1Q Operating Group Performance Consistent With Expectations
BlueScope Steel Price Target Cut 2.1% to A$23.50/Share by Jarden
ResMed Price Target Raised to $204.00/Share From $200.00 by RBC Capital
Berenberg Bank Sticks to Its Hold Rating for BHP Group Ltd (BHPLF)
BHP Group Poised for Growth: Strong Production and Strategic Outlook Justify Buy Rating
Analysts Offer Insights on Materials Companies: BHP Group Ltd (OtherBHPLF), AIC Mines Limited (OtherIAUFF) and Golden Minerals Co (AUMN)